A detailed history of Benjamin Edwards Inc transactions in Dexcom Inc stock. As of the latest transaction made, Benjamin Edwards Inc holds 12,054 shares of DXCM stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,054
Previous 9,726 23.94%
Holding current value
$1.07 Million
Previous $651,000 43.93%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$65.68 - $81.01 $152,903 - $188,591
2,328 Added 23.94%
12,054 $937,000
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $622,464 - $1.13 Million
9,726 New
9,726 $651,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.